Author:
Zaro Jennica L.,Wang Jeffery,Shen Wei-Chiang
Publisher
Springer International Publishing
Reference41 articles.
1. Aird RE, Thomson M, Macpherson JS, Thurston DE, Jodrell DI, Guichard SM (2008) ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG –136. Pharmacogenomics J 8(4):289–296
2. Behrens CR, Liu B (2014) Methods for site-specific drug conjugation to antibodies. mAbs 6(1):46–53
3. Bernardes GJ, Casi G, Trussel S, Hartmann I, Schwager K, Scheuermann J, Neri D (2012) A traceless vascular-targeting antibody-drug conjugate for cancer therapy. Angew Chem 51(4):941–944
4. Bross PF, Beitz J, Chen G, Chen XH, Duffy E, Kieffer L, Roy S, Sridhara R, Rahman A, Williams G, Pazdur R (2001) Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clinical cancer research: an official journal of the American Association for Cancer Res 7(6):1490–1496
5. Carter PJ, Senter PD (2008) Antibody-drug conjugates for cancer therapy. Cancer J 14(3):154–169
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献